
Raul G Nogueira MD
Vascular Neurology
Associate Professor, Neurology, Emory University School of Medicine
Join to View Full Profile
200 Lothrop StPittsburgh, PA 15213
Phone+1 412-647-8080
Fax+1 617-726-2894
Dr. Nogueira is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1999 - 2002
- Federal University of Ceara Faculty of MedicineClass of 1996
Certifications & Licensure
- NH State Medical License 2009 - Present
- PA State Medical License 2022 - 2026
- GA State Medical License 2010 - 2022
- ME State Medical License Active through 2012
- MA State Medical License 2002 - 2011
- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- Impact of next-generation delivery assist catheters and crossing strategy on reperfusion success in aspiration thrombectomy.Raul G Nogueira, Seán Fitzgerald, Miquel Murillo Artigues, Akorede Rei Adedeji, Liam Mullins
Interventional Neuroradiology. 2025-06-12 - Selection by Noncontrast Computed Tomography With or Without Computed Tomography Angiography Versus Computed Tomography Perfusion for Endovascular Therapy in Patients ...Yang Zhang, Yang Zhao, Bowen Deng, Simiao Wu, Raul G Nogueira
Journal of the American Heart Association. 2025-06-11 - Intravenous Glyburide in Medical and Endovascular-Treated Large-Core Stroke: A Subgroup Analysis of the CHARM Randomized Clinical Trial.W Taylor Kimberly, Jeffrey L Saver, Bruce C V Campbell, Gregory W Albers, Bradley J Molyneaux
Annals of Neurology. 2025-06-06
Press Mentions
- Brainomix Advances Stroke Care with Landmark FDA ClearanceApril 8th, 2025
- Two Trials Boost Intra-Arterial Lytics After Stroke ThrombectomyFebruary 11th, 2025
- GNT Pharma Reports Significant Improvements in Stroke Patients Treated with Its Pioneering Phase 3 Drug Nelonemdaz™December 11th, 2024
- Join now to see all
Grant Support
- NIH StrokeNet Regional Coordinating Center - University of Pittsburgh (STN-UP)UNIVERSITY OF PITTSBURGH AT PITTSBURGH2018–2028
- StrokeNet Thrombectomy Endovascular Platform (STEP)MEDICAL UNIVERSITY OF SOUTH CAROLINA2022–2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: